Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets
Recalled by Preferred Pharmaceuticals, Inc.
Drug recall
Preferred Pharmaceuticals, Inc.
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Preferred Pharmaceuticals, Inc. has recalled Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on December 24, 2025 and was initiated on November 17, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, with approximately 575 1x10 Foil Blister Packs affected. The company behind the recall is Preferred Pharmaceuticals, Inc., based in Anaheim, CA. The FDA describes the product as: “Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01”
Why was Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets recalled?
According to the FDA, the stated reason for the recall is: “Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.”
What should you do?
If you think you may have bought Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, compare it against the product description and identifying codes (Lot: J1325J, I1725P, EXP Date: 4/30/2027.) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Preferred Pharmaceuticals, Inc. or your local health authority.
About this recall
This recall was distributed in CA. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- December 24, 2025
- Recall started
- November 17, 2025
- Distributed in
- CA
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets recalled?+
According to the FDA: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark,…
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0239-2026. Information last synced from the FDA on July 5, 2026.